NIB Holdings Ltd · ASX:NHF
NIB — Shareholder Meeting (November 2020)
24 slides from NIB's shareholder meeting presentation, Nov 5, 2020
Slide 1: 2020 Annual General Meeting Presentation announcement
nib holdings limited t 13 14 63 Head Office f 02 4925 1999 22 Honeysuckle Drive Newcastle NSW 2300 e [email protected] abn 51 125 633 856 w nib.com.au 5 November 2020 For personal use only Company Announcements Office ASX Limited 20 Bridge Street SYDNEY NSW 2000 nib holdings limited 2020 Annual General
Slide 2: Annual General Meeting 5 November 2020
For personal use only Annual General Meeting 5 November 2020
Slide 3: Chairman Steve Crane
For personal use only Chairman Steve Crane 2
Slide 4: Acknowledgement of country
Acknowledgement of country For personal use only nib acknowledges the Australian Aboriginal and Torres Strait Islander peoples of this nation. We acknowledge the traditional custodians of the lands on which our company is located and where we conduct our business today. We pay our respects to ancest
Slide 5: nib's board and executive
nib’s board and executive Board For personal use only Steve Crane Chairman and Independent Non-Executive Director Donal O’Dwyer Independent Non-Executive Director Anne Loveridge Independent Non-Executive Director Lee Ausburn Independent Non-Executive Director David Gordon Independent Non-Executive D
Slide 6: Agenda
Agenda For personal use only Item 1 Consideration of Reports Item 2 Remuneration Report Item 3 Election of Mr David Gordon Item 4 Re-election of Ms Lee Ausburn Item 5 Re-election of Ms Anne Loveridge Item 6 Approval of Participation in Long-Term Incentive Plan 6
Slide 7: People's choice vote
People’s choice vote For personal use only Supporting mental health well Improving Aussies cancer Busting drug and alcohol myths beyond the sand risk score “These additional funds from nib foundation “With additional funding through nib “When given the necessary support to develop will enable WOW to
Slide 8: Chairman's presentation
For personal use only Chairman's presentation 9
Slide 9: Supporting our members, employees and the community through COVID-19
Supporting our members, employees and the community through COVID-19 For personal use only 10
Slide 10: Our purpose: your better health
Our purpose: your better health For personal use only • Accelerated plans to better predict disease risk amongst members • Our value proposition is as much about healthcare “prevention” as it is “cure” • Creation of Honeysuckle Health joint venture • Shift from "sick care" to "well care" • 2020 prem
Slide 11: nib foundation
nib foundation For personal use only $2.1m Towards community and health prevention initiatives in FY20 >740,000 People reached through partnerships and grants in FY20 >$21m Funding distributed since 2008 12
Slide 12: FY20: Group results
FY20: Group results For personal use only $2.5b $150.1m 34.8 total Group revenue Group UOP Group NPS up 3.4% down 25.6% up 2.3 Statutory operating profit $118.1m down 36.0% $16.6m $89.2m 19.8cps net investment income NPAT statutory EPS down 54.0% down 40.3% down 40.0% 14.0cps full year dividend payo
Slide 13: Sustainability at nib
Sustainability at nib For personal use only nib placed 87th globally in the Refinitiv 2020 Diversity and Inclusion Index and was one of only 9 Australian companies included in the index Inaugural Reconciliation Action Plan published Our partnership with Māori iwi, Ngāti Whātua Ōrākei is designed to
Slide 14: Board succession
Board succession For personal use only • Succession planning and ensuring we have the right skills mix, diversity and experience is a priority. • Retirement of Ms Christine McLoughlin in September 2020. • Appointment of Mr David Gordon in May 2020. 15
Slide 15: Thank you
For personal use only Thank you 16
Slide 16: Chief Executive Officer & Managing Director Mark Fitzgibbon
For personal use only Chief Executive Officer & Managing Director Mark Fitzgibbon 17
Slide 17: Our purpose: your better health
Our purpose: your better health FY20 snapshot1 For personal use only 352,269 3,558,594 hospital admissions ancillary visits 5,431 knee and hip replacements 1,105,662 dental visits 865 angioplasties 376,100 optical visits 3,806 baby deliveries 1. Underwriting segments - arhi, iihi & nz, excludes nib
Slide 18: FY20: Group results
FY20: Group results For personal use only $2.5b $150.1m $16.6m total Group revenue Group UOP net investment income up 3.4% down 25.6% down 54.0% Statutory operating profit $118.1m down 36.0% $89.2m 19.8cps 14.0cps NPAT statutory EPS full year dividend down 40.3% down 40.0% down from 23.0cps 14.5% 34
Slide 19: FY20: Summary observations
FY20: Summary observations For personal use only Business fundamentals remain strong Business silver linings - arhi policyholder growth of 1.9% (accounted for 41.5% of total - Group remains well capitalised with $57.0 million in available industry net growth) with premium revenue ▲2.9% and net capit
Slide 20: Q1 FY21 update
Q1 FY21 update Sales Lapse Net growth For personal use only 3 months to 30 September FY21 FY20 FY21 FY20 FY21 FY20 arhi 32,006 29,451 (22,006) (23,272) 10,000 6,179 iihi 15,288 30,360 (22,113) (23,438) (6,825) 6,922 NZ1 4,253 7,9302 (2,583) (3,113) 1,670 4,8172 nib Travel 14,207 329,891 3 months to
Slide 21: Business strategy
Business strategy For personal use only Personalised Affordability and Grow the core Economies Racing the Red healthcare sustainability (arhi) of scope Queen 22
Slide 22: Personalisation, payer to partner (P2P) and Honeysuckle Health
Personalisation, payer to partner (P2P) and Honeysuckle Health For personal use only Data science and insight Healthcare products and services • Individual risk profiling and guidance • Disease prevention and management • Population risk stratification • Direct delivery • Health management strategy
Slide 23: Business update: outlook
Business update: outlook For personal use only arhi iihi New Zealand nib Travel China - Strong sales - Sales continue to be - Strong sales - Sales extremely - Good progress performance and hampered by travel performance and weak given limited being made in retention restrictions retention internatio
Slide 24: Thank you
For personal use only Thank you 25